5Fischer A, Human primm'y immunodeficiency diseseas. Immuni- ty, 2007,27 ( 6 ) : 835 -845.
6AI-Herz W, Bousfiha A, Casanova JL, et al. Primary immunode- ficiency diseases:an update on the classification from the inter- national union of immunological societies expert committee for primary inununodeficiency. Front Immuno1,2011,2 :54.
7Zhu Q,Watanabe C, Liu T, et al. Wiskott-Ald rich syndrome/ X-linked throlnbocytopenia:WASP gene mutations, protein ex- pression, and phenotype. Blood, 1997,90 (7) :2680-2689.
8Buckley RH. A historical review of bone marrow transplantation for i mmunodeficiencies. J Allery Clin Irmnuno1,21304 ,113 (4) :793- 800.
9Kasztalska K, Ciebiada M, Cebula-Obrzut B, et al. Intravenous immunoglobulin replacement therapy in the treatment of patients with common variable immunodeficiency disease:an open-label prospective study. Clin Drug Invest,2011,31 (5) :299-307.
10Pourpak Z, Aghamohammadi A, Sedighipour L, et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variab]e immunodeficien- cy. J Microbiol hnmunol Infect,2006,39(2) :114-120.
